An average of $3.9 billion per year in avoidable healthcare utilization costs would be realized if all U.S. adults older than 55 years diagnosed with age-related eye disease were to use lutein and zeaxanthin dietary supplements at preventive intake levels, according to a new economic report released Thursday by the Council for Responsible Nutrition.
CVS/pharmacy has become the only pharmacy retailer to receive the Arthritis Foundation's 'Partner for Better Living' designation, a new distinction from the Arthritis Foundation that recognizes CVS/pharmacy as a company committed to addressing the needs of people with arthritis through arthritis-related products, services or resources.
MyFitnessPal on Thursday published its first user data study, uncovering a new trend in which people share health-related goals, activities and personal health content with their friends, colleagues and relatives, online and off.
National Geographic is partnering with Live Prepared, a division of Blue Chip Group and a leader in emergency preparedness, to bring consumers a line of high-quality preparedness products for natural disasters and unexpected events.
Amazon has introduced same-day delivery to three cities, including Dallas, Los Angeles and San Francisco, and has discontinued same-day delivery in the Las Vegas market, according to a report published Thursday in the Washington Post.
Canadian grocer Loblaw, which recently acquired pharmacy retailer Shoppers Drug Mart, is sharpening its focus on health and wellness, and envisions pharmacists one day serving as nutrition experts, according to a Financial Post article.
Seattle Mayor Ed Murray on Thursday unveiled a plan to increase the city’s minimum wage to $15. Although Murray said the hike has broad support across local government, business and labor communities, the City Council still has to vote on the proposal.
GlaxoSmithKline on Wednesday announced that the Food and Drug Administration approved Incruse Ellipta (umeclidinium), which is used for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, or COPD, including chronic bronchitis and/or emphysema.